Bank of America’s BioCardia, Inc. Warrant BCDAW Stock Holding History

Bank of America’s Portfolio BCDAW Stock Details BCDAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,735	Closed	-$69	–	8537
2024 Q2	$69	Hold	5,735	–	–	﹤0.01%	7786
2024 Q1	$86	Hold	5,735	–	–	﹤0.01%	7413
2023 Q4	$69	Hold	5,735	–	–	﹤0.01%	7455
2023 Q3	$1.43K	Hold	5,735	–	–	﹤0.01%	7189
2023 Q2	$4.3K	Hold	5,735	–	–	﹤0.01%	7024
2023 Q1	$4.76K	Hold	5,735	–	–	﹤0.01%	7081
2022 Q4	$4.74K	Hold	5,735	–	–	﹤0.01%	7064
2022 Q3	$1K	Hold	5,735	–	–	﹤0.01%	7713
2022 Q2	$2K	Hold	5,735	–	–	﹤0.01%	7808
2022 Q1	$2K	Hold	5,735	–	–	﹤0.01%	8061
2021 Q4	$6K	Buy	+5,735	New	+$7.38K	﹤0.01%	7808

Bank of America's BCDAW Position: Q3 2024 in Review

Bank of America sold out of BioCardia, Inc. Warrant (BCDAW) in Q3 2024, closing a stake of 5,735 shares — an estimated $69 sold.

Bank of America first reported a position in BCDAW in Q4 2021 and held it in 11 quarters. The position peaked at $6K in Q4 2021. 0 funds tracked by Wall St. Rank hold BCDAW as of Q3 2024.

Bank of America reported no remaining BioCardia, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
Bank of America sold 5,735 BioCardia, Inc. Warrant shares in Q3 2024, an estimated $69.
Bank of America first reported a position in BioCardia, Inc. Warrant in Q4 2021 and held it in 11 quarters.
Bank of America's BioCardia, Inc. Warrant position peaked at $6K in Q4 2021.
0 funds tracked by Wall St. Rank held BioCardia, Inc. Warrant as of Q3 2024.

Based on Bank of America's 13F filing for Q3 2024, filed 14 Nov 2024.